People · Operator
Named in public records as an officer, director or promoter · active 2014–2020 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Retrotope, Inc. | — | Biotechnology | Series B | $73.5M | $963.1M | 2014 |
Mikhail Shchepinov at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Mikhail Shchepinov on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Corey McCann | 1 | 5 |
| Peter Milner | 1 | 2 |
| Charles Cantor | 1 | 2 |
| Harry Saal | 1 | 2 |
| Ernst-Guenter Afting | 1 | 2 |
| George Garibaldi | 1 | 1 |
| Nitin Mehta | 1 | 1 |
| Yvonne Kao | 1 | 1 |
| Robert F. Johnston | 1 | 1 |
| Anil Kumar | 1 | 1 |
| Harry F. Saal | 1 | 1 |
| Leonardus H.T. Van Der Ploeg | 1 | 1 |
| Robert Molinari | 1 | 1 |
| Timur Artemev | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.